Form DEF 14A BAIN Capital Private Credit for: 20 April
Source: Investing.com News
Category macro
Form S-1 Amesite Operating Co for: 20 April
Source: Investing.com News
Form DEF 14A Doordash for: 20 April
Source: Investing.com News
Form DEF 14A United States Antimony Corporation for: 20 April
Source: Investing.com News
Form DEF 14A Exponent for: 20 April
Source: Investing.com News
Form DEF 14A Larimar Therapeutics for: 20 April
Source: Investing.com News
Nektar Therapeutics Reports $741.7 Million in Cash and Investments as of April 1
Source: Investing.com News
Form PRE 14A Dentsply Sirona Inc for: 20 April
Source: Investing.com News
Form 144 Roivant Sciences Ltd. for: 20 April
Source: Investing.com News
Form 13D/A SPYRE Therapeutics for: 20 April
Source: Investing.com News